EUVIMEDEUVIMED entdecken
Crossref

Patient preferences toward the attributes of treatment used for inflammatory bowel disease in Saudi Arabia: Subgroup analysis from an international multicenter discrete choice experiment

Nahla Azzam, Diane Mourad, Mahmoud Mosli, Eman Al Sulais, Mansour Altuwaijri, Yaser Meeralam, Olga Fadeeva, Amr Elgharbawy

Saudi Journal of Gastroenterology · 06.07.2026

DOI: 10.4103/sjg.sjg_89_26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Journal of Gastroenterology, online erschienen am 06.07.2026. Verfasst von Nahla Azzam und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel diseases (IBD), including Crohn’s disease (CD), and ulcerative colitis (UC), are chronic autoimmune disorders with increasing prevalence in Saudi Arabia (KSA). Understanding patient treatment preferences is important for improving adherence and quality of life. This study evaluated treatment preferences in KSA within the context of the overall five-country cohort (Argentina, Australia, Brazil, Taiwan, and KSA), without conducting formal cross-country comparisons.

Methods

A cross-sectional survey (October 2022–May 2023) used discrete choice experiments (DCE) to assess preferences for treatment attributes, including safety, efficacy, and route of administration (RoA). Adults (≥18 years) with self-reported CD or UC receiving treatment for ≥6 months were included.

Results

Data from 353 patients with CD and 353 with UC were analyzed, including 102 from KSA (51 CD, 51 UC). Preferences in KSA were largely consistent with the overall cohort. CD patients prioritized long-term remission, while UC patients valued corticosteroid-free remission at 1 year. Descriptively, KSA patients appeared to place relatively greater emphasis on safety attributes compared with the overall cohort—particularly serious adverse events (AEs) in both CD and UC, and mild AEs in UC—and less emphasis on mucosal healing and RoA. Abdominal pain (CD) and rectal bleeding (UC) most affected quality of life and daily activities. KSA patients also reported lower exposure to advanced therapies (0% in CD and 11.8% in UC). However, given the limited sample size and absence of formal statistical testing, these observations between countries should be interpreted as exploratory.

Conclusions

Personalized IBD management in KSA is needed. Incorporating patient preferences into clinical decision-making may improve adherence and outcomes.

Schlagwörter

Stichwörter der Autor:innen

Crohn’s diseaseKingdom of Saudi Arabiahealth accessinflammatory bowel diseasespatient centered carepatient reported outcome measuresquality of lifetreatment preferencesulcerative colitis

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Medical Affairs and Patient Services (PSP), EAMEA (Eurasia, Middle East and Africa), Takeda Pharmaceuticals FZE (Lebanon Rep Office), Beirut, Lebanon.
  • Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.
  • Inflammatory Bowel Disease Unit, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
  • Division of Gastroenterology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
  • Digestive and Liver Health and Advanced Endoscopy Center, King Abdullah Medical City, Makkah, Saudi Arabia.

Zitieren

APA

Azzam, N., Mourad, D., Mosli, M., Al Sulais, E., Altuwaijri, M., Meeralam, Y., Fadeeva, O., & Elgharbawy, A. (2026). Patient preferences toward the attributes of treatment used for inflammatory bowel disease in Saudi Arabia: Subgroup analysis from an international multicenter discrete choice experiment. Saudi Journal of Gastroenterology. https://doi.org/10.4103/sjg.sjg_89_26

Vancouver

Azzam N, Mourad D, Mosli M, Al Sulais E, Altuwaijri M, Meeralam Y, et al. Patient preferences toward the attributes of treatment used for inflammatory bowel disease in Saudi Arabia: Subgroup analysis from an international multicenter discrete choice experiment. Saudi Journal of Gastroenterology. 2026. doi:10.4103/sjg.sjg_89_26

BibTeX
@article{Azzam2026,
  author = {Azzam, Nahla and Mourad, Diane and Mosli, Mahmoud and Al Sulais, Eman and Altuwaijri, Mansour and Meeralam, Yaser and Fadeeva, Olga and Elgharbawy, Amr},
  title = {Patient preferences toward the attributes of treatment used for inflammatory bowel disease in Saudi Arabia: Subgroup analysis from an international multicenter discrete choice experiment},
  journal = {Saudi Journal of Gastroenterology},
  year = {2026},
  doi = {10.4103/sjg.sjg_89_26}
}
Kostenlos starten →